Document is current
Any future updates will be listed below
-
Authors
Mathieu, Sylvain https://orcid.org/0000-0003-2017-3227
Lambert, C.
Fayet, Françoise https://orcid.org/0000-0002-2502-8064
Couderc, Marion https://orcid.org/0000-0002-2001-1132
Beauger, Marine https://orcid.org/0009-0002-8491-985X
Malochet, Sandrine https://orcid.org/0000-0003-3502-4689
Pickering, Marie-Eva https://orcid.org/0000-0001-6750-2038
Tournadre, Anne https://orcid.org/0000-0002-5025-0214
Soubrier, Martin https://orcid.org/0000-0001-9349-0720
- License Information
-
More Information
Article History
Received: 7 June 2023
Accepted: 23 July 2023
First Online: 11 August 2023
Declarations
:
: Sylvain Mathieu has received personal fees from Bristol Myers Squibb, Pfizer, Abbvie, Novartis, Roche, Chugai, Merck, Sharp, and Dohme, but not related to the submitted work. All other authors have no conflicts of interest to declare.
: The study was approved by the local ethics committee (IRB00013412, “CHU de Clermont-Ferrand IRB #1”, IRB number 2022-CF026) in compliance with French legislation for the protection of the data of individuals.
